Refractory sarcoidosis presenting as chylothorax: a case report

Sarcoidosis is a systemic granulomatous autoinflammatory disease that primarily affects lymphoid organs, the skin, and the lungs. While recurrent pleural effusion is documented in sarcoidosis, chylothorax is exceedingly rare. We present a male patient in his seventies who presented to the emergency department with long-standing fatigue, a ten-kilogram weight loss over six months, new-onset snoring, and nasal congestion. Evaluations, including respiratory function tests and chest computed tomography, revealed findings consistent with sarcoidosis, such as hilar lymphadenopathy, reduced carbon monoxide diffusion, and elevated serum angiotensin-converting enzyme levels, along with pleural effusion. Analysis of the pleural fluid showed it to be exudative, with high triglycerides level. We concluded that chylothorax resulted from extensive lymph node involvement. During two years of follow-up, combinations of methylprednisolone and other immunosuppressants were ineffective, leading to disease progression. Infliximab was then initiated, resulting in a dramatic clinical response and improvement in Positron Emission Tomography/Computerized Tomography (PET/CT) imaging.

Authors

Publication Details

Journal
Chest Disease Reports
Published
2025-01-16
DOI
https://doi.org/10.4081/cdr.13.13300
Citations
1
Primary Topic
Sarcoidosis and Beryllium Toxicity Research
Type
article
Field-Weighted Citation Impact
1.16
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Refractory sarcoidosis presenting as chylothorax: a case report

Merih Bırlık, Hüseyin Döngelli
1 citations
Chest Disease Reports
Sarcoidosis and Beryllium Toxicity Research
1.16
article

Refractory sarcoidosis presenting as chylothorax: a case report

Merih Bırlık, Hüseyin Döngelli
article en
1 citations

Abstract

Sarcoidosis is a systemic granulomatous autoinflammatory disease that primarily affects lymphoid organs, the skin, and the lungs. While recurrent pleural effusion is documented in sarcoidosis, chylothorax is exceedingly rare. We present a male patient in his seventies who presented to the emergency department with long-standing fatigue, a ten-kilogram weight loss over six months, new-onset snoring, and nasal congestion. Evaluations, including respiratory function tests and chest computed tomography, revealed findings consistent with sarcoidosis, such as hilar lymphadenopathy, reduced carbon monoxide diffusion, and elevated serum angiotensin-converting enzyme levels, along with pleural effusion. Analysis of the pleural fluid showed it to be exudative, with high triglycerides level. We concluded that chylothorax resulted from extensive lymph node involvement. During two years of follow-up, combinations of methylprednisolone and other immunosuppressants were ineffective, leading to disease progression. Infliximab was then initiated, resulting in a dramatic clinical response and improvement in Positron Emission Tomography/Computerized Tomography (PET/CT) imaging.

Chest Disease ReportsVol. 13
Openalex Percentile: Top 26%
Sarcoidosis and Beryllium Toxicity Research
1.16
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Refractory sarcoidosis presenting as chylothorax: a case report — Merih Bırlık, Hüseyin Döngelli · Chest Disease Reports (2025) | TGRS Research Map | TGRS